Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Vomiting 1Shoulder Pain 1Postoperative Nausea and Vomiting 1Muscular Atrophy 1Lymphedema 1Glioma 1Gastrointestinal Neoplasms 1Edema 1Colorectal Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Electric Stimulation × Clear all
NCT07465796 2026-06-03

CIPHER

Coherence Neuro Australia Pty Limited

Phase NA Recruiting
10 enrolled
CNS

Glioma, Neoplasms

NCT02158832 2017-08-30

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

McMaster University

Phase NA Withdrawn
Breast

Breast Neoplasms, Edema, Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡